Target intelligence / Profile preview

Long intergenic non-protein coding RNA 272 (LINC00272)

Target
LINC00272
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 272 (LINC00272) is a long intergenic non-coding RNA (lincRNA) gene, meaning it produces an RNA transcript over 200 nucleotides in length that does not code for a protein and does not overlap nearby protein-coding genes[1][3][5]. LINC00272 is part of the broader class of long non-coding RNAs, which are known to regulate gene expression, chromatin state, and other cellular processes primarily by acting as molecular scaffolds or guides to influence the activity of regulatory complexes[3][5]. Although the general class of lincRNAs is associated with a range of biological roles and disease associations (including cancer)[5], there is currently no direct evidence in the provided results that LINC00272 itself is a validated therapeutic target, a biomarker, or a focus of drug interaction studies. It is primarily classified as a regulatory non-coding RNA with possible, but undefined, roles in gene regulation[1][3][5].

Other names
RP1-223H12.3C1orf120NCRNA00272
02

Biological functions

Gene regulation (regulation of gene expression in cis or trans)Chromatin remodelingRNA stabilizationPossible enhancer-associated regulation
03

Disease associations

Other (Some lincRNAs are implicated in cancer and other diseases, but there is no direct evidence for LINC00272's disease role in the results above)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 272 (LINC00272).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 272 (LINC00272).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call